NASDAQ: HWKN

HAWKINS INC

CIK 0000046250 · SIC 5160 · Chemicals & Allied Products

Mid Revenue $1.1B Assets $1.0B as of Oct 30, 2026

We are a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for our Water Treatment, Food and Health Sciences, and Industrial Solutions customers. We believe that we create value for our customers through superb service and… About this business →

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (FPS 10-K) is open in full — no account needed.

10-Q Filed Oct 26, 2026 · Period ending Sep 27, 2026

Summary not yet generated.

8-K Filed Oct 26, 2026 · Period ending Oct 26, 2026

Summary not yet generated.

Partner

Trade HWKN commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Aug 14, 2026 · Period ending Aug 13, 2026

Summary not yet generated.

8-K Filed Aug 3, 2026 · Period ending Jul 29, 2026

Summary not yet generated.

10-Q Filed Jul 29, 2026 · Period ending Jun 28, 2026

Summary not yet generated.

10-K Filed May 13, 2026 · Period ending Mar 29, 2026

Summary not yet generated.

10-K Filed May 14, 2025 · Period ending Mar 30, 2025

Summary not yet generated.

10-K/A Filed Jun 19, 2015 · Period ending Mar 29, 2015

Summary not yet generated.

10-Q/A Filed Aug 23, 2011 · Period ending Jul 3, 2011

Summary not yet generated.

Latest financial statements

From 10-Q filed Oct 26, 2026 (period ending Sep 27, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Income (Unaudited)

(In thousands, except share and per-share data)

Description Three months ended September 27, 2026 Three months ended September 28, 2025 Six months ended September 27, 2026 Six months ended September 28, 2025
Sales 313,817 280,434 629,492 573,706
Cost of sales (237,211) (212,791) (478,879) (433,701)
Gross profit 76,606 67,643 150,613 140,005
Selling, general and administrative expenses (34,700) (33,703) (70,035) (64,732)
Operating income 41,906 33,940 80,578 75,273
Interest expense, net (2,643) (3,832) (5,416) (7,101)
Other income 264 721 1,689 1,663
Income before income taxes 39,527 30,829 76,851 69,835
Income tax expense (11,746) (8,231) (20,816) (18,062)
Net income 27,781 22,598 56,035 51,773
Weighted average number of shares outstanding basic 20,710,228 20,737,743 20,743,855 20,727,614
Weighted average number of shares outstanding diluted 20,783,044 20,845,744 20,827,219 20,837,595
Basic earnings per share 1.34 1.09 2.70 2.50
Diluted earnings per share 1.34 1.08 2.69 2.48
Cash dividends declared per common share 0.20 0.19 0.39 0.37

Condensed Consolidated Balance Sheets (Unaudited)

(In thousands, except share data)

Description September 27, 2026 March 29, 2026
ASSETS
CURRENT ASSETS:
Cash and cash equivalents 7,100 3,914
Trade accounts receivables, net 149,281 139,796
Inventories 92,947 78,199
Prepaid expenses and other current assets 7,793 9,556
Total current assets 257,121 231,465
Property, plant, and equipment 509,360 489,662
Less accumulated depreciation 237,614 223,406
Net property, plant, and equipment 271,746 266,256
OTHER ASSETS:
Right-of-use assets, net 17,170 16,840
Goodwill 224,439 223,042
Intangible assets, net 224,455 232,887
Deferred compensation plan asset 15,649 12,812
Other 1,472 2,988
Total other assets 483,185 488,569
Total assets 1,012,052 986,290
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable trade 69,609 59,835
Accrued payroll and employee benefits 15,746 20,092
Income tax payable 5,025 98
Environmental remediation 7,700 7,700
Other current liabilities (Note 8) 14,676 17,119
Total current liabilities 112,756 104,844
LONG-TERM LIABILITIES:
Long-term debt 229,000 244,000
Long-term lease liabilities 14,699 14,457
Pension withdrawal liability 2,563 2,763
Deferred income taxes 26,143 25,110
Deferred compensation liability 16,941 14,850
Earnout liabilities 45,985 44,898
Other long-term liabilities 276 1,359
Total long-term liabilities 335,607 347,437
Total liabilities 448,363 452,281
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' EQUITY:
Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,674,812 and 20,752,138 shares issued and outstanding as of September 27, 2026 and March 29, 2026, respectively 207 208
Additional paid-in capital 14,739 32,678
Retained earnings 548,041 500,142
Accumulated other comprehensive income 702 981
Total shareholders’ equity 563,689 534,009
Total liabilities and shareholders’ equity 1,012,052 986,290

Condensed Consolidated Statements of Cash Flows (Unaudited)

(In thousands)

Description Six months ended September 27, 2026 Six months ended September 28, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income 56,035 51,773
Reconciliation to cash flows:
Depreciation and amortization 28,240 25,553
Change in fair value of earnout liabilities 1,087 (1,048)
Operating leases 2,121 1,881
Gain on deferred compensation assets (1,689) (1,664)
Deferred income taxes 1,131 —
Stock compensation expense 4,168 4,587
Other, net (60) 8
Changes in operating accounts providing (using) cash:
Trade receivables (9,949) 5,140
Inventories (14,550) (5,196)
Accounts payable 9,676 (11,013)
Accrued liabilities (6,320) (4,209)
Lease liabilities (2,376) (1,897)
Income taxes 5,173 4,082
Other, net 2,801 3,034
Net cash provided by operating activities 75,488 71,031
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant, and equipment (22,355) (24,342)
Acquisitions (5,200) (162,508)
Proceeds from asset disposals 517 1,037
Net cash used in investing activities (27,038) (185,813)
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash dividends declared and paid (8,136) (7,723)
New shares issued 1,681 1,609
Payroll taxes paid in exchange for shares withheld (5,143) (3,028)
Shares repurchased (18,646) —
Payments on senior secured revolving loan (20,000) (40,000)
Payments for debt issuance costs — (764)
Borrowings on senior secured revolving loan 5,000 170,000
Other (20) —
Net cash (used in) provided by financing activities (45,264) 120,094
NET INCREASE IN CASH AND CASH EQUIVALENTS 3,186 5,312
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 3,914 5,103
CASH AND CASH EQUIVALENTS, END OF PERIOD 7,100 10,415
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for income taxes 14,512 13,980
Cash paid for interest 5,480 7,182
Noncash investing activities capital expenditures in accounts payable 2,273 1,568

Amounts as printed on the EDGAR/iXBRL face — (In thousands, except share and per-share data); (In thousands, except share data); (In thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

About HAWKINS INC

Source: Item 1 (Business) from the 10-K filed May 13, 2026. Description as filed by the company with the SEC.

ITEM 1. BUSINESS

We are a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for our Water Treatment, Food and Health Sciences, and Industrial Solutions customers. We believe that we create value for our customers through superb service and support, quality products, personalized applications and trustworthy, creative employees.

We conduct our business in three segments: Water Treatment, Food and Health Sciences, and Industrial Solutions.

Water Treatment Segment. Our Water Treatment Group specializes in providing chemicals, filtration media and systems, equipment, services and solutions for potable water, municipal and industrial wastewater, industrial process water, mainly non-residential swimming pool water and agricultural water. This group has the resources and flexibility to treat systems ranging in size from a single small well to a multi-million-gallon-per-day facility.

This group utilizes delivery routes operated by our employees who typically serve as route driver, salesperson and trained technician to deliver our products and diagnose our customers’ water treatment needs. We believe that the high level of service provided by these individuals allows us to serve as the trusted water treatment expert for many of the municipalities and other customers that we serve. In addition to meeting customers' chemistry needs, our employees sell and service equipment, including tanks, valves, and pumps, and offer a large variety of filtration media and equipment to treat water for the short-term through rental of filtration units and the long-term with ability to design, engineer, and build full-scale filtration systems capabilities.

Read full description ↓

The Water Treatment Group operates out of 53 warehouses in 28 states, primarily located in the eastern two-thirds of the United States, supplying products and services to customers across that footprint. We expect to continue to invest in existing and new branches to expand the group’s geographic coverage. Our Water Treatment Group has historically experienced higher sales during April to September, primarily due to a seasonal increase in chemicals used by municipal water treatment facilities and pools.

Food and Health Sciences Segment. Our Food and Health Sciences Group specializes in processing and formulation solutions as well as ingredient distribution to manufacturers in the nutrition, food, pharmaceutical, and agricultural markets. This group offers a diverse product portfolio including base chemistry, acid based reactions, minerals, vitamins and amino acids, excipients, botanicals and herbs, sweeteners and enzymes, fertilizers, and food-grade and pharmaceutical salts and ingredients.

The Food and Health Sciences Group relies on a specially trained sales staff that works directly with customers on their specific needs. Our group’s extensive product portfolio, combined with value-added services, including product formulation, sourcing, distribution, processing and blending, positions this segment as a one-stop ingredient solutions provider to its customers. This group also follows rigorous quality control and compliance processes to provide reliable, high-quality products to its customers. They operate primarily out of facilities in California, New York, Minnesota, and Illinois, and their products are sold nationally, and in certain cases, internationally. Agricultural sales within this group have seasonality based on planting seasons.

Industrial Solutions Segment. Our Industrial Solutions Group specializes in providing industrial chemicals, products and services to industries such as industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing. This group’s principal products are acids and alkalis. This segment receives, stores and distributes various chemicals in bulk quantities, including liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia and potassium hydroxide. They perform customer blending of chemicals according to customer formulas and specifications and repackage bulk industrial chemicals to sell in smaller quantities to our customers. The Industrial Solutions group relies on a specially trained sales staff that works directly with customers on their specific needs. This group conducts its business primarily through manufacturing locations and terminal operations.

Our three groups provide significant synergies to one another because certain raw materials used in each segment are similar, creating opportunities for buying power among two or more groups and competitive cost positions. In addition, the segments share some manufacturing facilities and resources, which leverage fixed costs.

1

Raw Materials. We have numerous suppliers, including many of the major chemical producers in the United States. We source our health and nutrition ingredients from a wide array of domestic and international vendors. We typically have distributorship agreements or supply contracts with our suppliers that are periodically renewed. We believe that most of the products we purchase can be obtained from alternative sources should existing relationships be terminated. Our operations are substantially dependent upon the availability of our raw materials. While we believe that we have adequate sources of supply for our raw materials and product requirements, we cannot be sure that supplies will be consistently available in the future. In the event that certain raw materials become generally unavailable, suppliers may extend lead times or limit or cut off the supply of materials to us. As a result, we may not be able to supply or manufacture the corresponding products for our customers.

Intellectual Property. Our intellectual property portfolio is of economic importance to our business. When appropriate, we have pursued, and we will continue to pursue, patents covering our products. We have also obtained trademarks for certain of our products to distinguish them from our competitors’ products. We regard many of the formulas, information and processes that we generate and use in the conduct of our business as proprietary and protectable under applicable copyright, patent, trademark, trade secret and unfair competition laws.

Customer Concentration. In fiscal 2026, 2025, and 2024, none of our customers accounted for 10% or more of our total sales.

Competition. We operate in a competitive industry and compete with many producers, distributors and sales agents offering products equivalent to substantially all of the products we offer. Many of our competitors are larger than we are and may have greater financial resources, although no one competitor is dominant in all of the markets we serve. We compete by offering quality products with outstanding customer service at competitive prices coupled with value-added services or product formulation where needed. Because of our long-standing relationships with many of our suppliers, we are often able to leverage those relationships to obtain products when supplies are limited or to obtain competitive pricing.

Working Capital. Due to the nature of our operations, which includes purchases of large quantities of bulk chemicals, the timing of purchases can result in significant changes in working capital and the resulting operating cash flow. Historically, our cash requirements for working capital increase during our first fiscal quarter.

Regulatory Matters. We are subject to numerous federal, state and local environmental, health and safety laws and regulations in the jurisdictions in which we operate, including laws and regulations relating to the management, storage, transportation and disposal of chemicals and wastes; product regulation; air, water and soil contamination; and the investigation and cleanup of any spills or releases that may result from our management, handling, storage, sale, or transportation of chemicals and other products. In addition, societal concerns regarding the safety of chemicals in commerce and their potential impact on the environment have resulted in a growing trend towards increasing levels of product safety and environmental protection regulations. These concerns have led to, and could continue to result in, more stringent regulatory intervention by governmental authorities.

In addition, we operate a fleet of approximately 400 commercial vehicles with power units, primarily in our Water Treatment Group, which are highly regulated, including by the U.S. Department of Transportation (“DOT”). The DOT governs transportation matters, including authorization to engage in motor carrier service, including the necessary permits to conduct our businesses, equipment operation, and safety.

The manufacture, packaging, labeling, advertising, promotion, distribution and sale of our agricultural, food, pharmaceutical and health and nutrition products are subject to regulation by numerous national and local governmental agencies in the United States and other countries. The primary regulatory bodies in the United States are the Food and Drug Administration (the “FDA”), the Environmental Protection Agency, the United States Department of Agriculture and the Federal Trade Commission, and we are also subject to similar regulators in other countries. In particular, the FDA’s current good manufacturing practices (“GMPs”) describe policies and procedures designed to ensure that nutraceuticals, pharmaceuticals and dietary supplements are produced in a quality manner, do not contain contaminants or impurities, and are accurately labeled and cover the manufacturing, packaging, labeling and storing of products, with requirements for quality control, design and construction of manufacturing plants, testing of ingredients and final products, record keeping, and complaints processes.

Further information related to government regulation applicable to our business is included in this Annual Report on Form 10-K, in Part I, Item 1A - Risk Factors.

2

Human Capital. Our team is a key to our success and we are committed to creating a workplace that attracts top talent, develops leaders and drives performance on behalf of our customers and shareholders.

We strive to recruit the best people for the job regardless of race, color, nationality, gender, age, disability, sexual orientation or any other status protected by law. It is our policy to comply fully with all applicable laws relating to discrimination in the workplace and we are committed to advancing an inclusive, collaborative and respectful culture.

The health and safety of our employees is our highest priority. We work to ensure our employees have a thorough understanding of health and safety precautions that need to be taken in all business functions. Specific safety programs include process controls, safety training, safety committees, safety audits, incident investigation and improvement measures.

We strive to provide employees with competitive wages commensurate with their skill levels, experience, knowledge and the regional market. Full-time employees are eligible for health, dental and vision insurance, paid and unpaid leaves, 401(K) plan, retirement plans, life and disability/accident coverage and our employee assistance program.

As of March 29, 2026, we had approximately 1,200 employees across the United States, substantially all of which were full-time employees. Approximately 45% of our employees were female or racially and ethnically diverse, and approximately 8% were covered by a collective bargaining agreement.

Available Information. Our Internet address is www.hawkinsinc.com. We have made available, free of charge, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and, if applicable, amendments to those reports, as soon as reasonably practicable after we electronically file these materials with, or furnish them to, the Securities and Exchange Commission ("SEC"). Reports of beneficial ownership filed by our directors and executive officers pursuant to Section 16(a) of the Exchange Act are also available on our website. We are not including the information contained on our website as part of, or incorporating it by reference into, this Annual Report on Form 10-K. The SEC also maintains an internet site that contains reports, proxy and information statements, and other information regarding our company at http://www.sec.gov.

Information about our Executive Officers and Key Employees

Our current executive officers and key employees, their ages and offices held, are set forth below:

Name Age Office

Patrick H. Hawkins 55 Chief Executive Officer and President

Jeffrey P. Oldenkamp 53 Executive Vice President, Chief Financial Officer and Treasurer

Drew M. Grahek 56 Vice President — Operations

Greg A. Jones 45 Vice President — Food and Health Sciences

Douglas A. Lange 56 Vice President — Water Treatment

Daniel A. Louismet 40 Vice President, General Counsel and Secretary

David J. Mangine 68 Vice President — Industrial Solutions

Shirley A. Rozeboom 64 Vice President — Stauber

Patrick H. Hawkins has been our Chief Executive Officer and President and member of our board since 2011. Mr. Hawkins has held the position of President since 2010. He joined the Company in 1992 and served as the Business Director - Food and Pharmaceuticals, a position he held from 2009 to 2010. Previously he served as Business Manager - Food and Co-Extrusion Products from 2007 to 2009 and Sales Representative - Food Ingredients from 2002 to 2007. He previously served the Company in various other capacities, including Plant Manager, Quality Director and Technical Director.

Jeffrey P. Oldenkamp has been our Executive Vice President, Chief Financial Officer and Treasurer since October 2021. Mr. Oldenkamp joined Hawkins in May 2017 and assumed the role of Chief Financial Officer, Vice President and Treasurer in June 2017. Prior to joining Hawkins, Mr. Oldenkamp was with MTS Systems Corporation, a supplier of high-performance test systems and sensors, where he served as Chief Financial Officer from 2015 to May 2017 and as Vice President of Finance for the MTS Test business from 2014 to 2015, and with Nilfisk-Advance, Inc., a global manufacturer of professional cleaning equipment, where he served as Americas Operations Chief Financial Officer and Vice President from 2012 to 2014.

3

Drew M. Grahek has been our Vice President - Operations since September 2018. Prior to joining Hawkins, Mr. Grahek was Adjunct Faculty at the University of Minnesota College of Continuing Education and a Business Administrator in the Archdiocese of St. Paul and Minneapolis from June 2017 to June 2018; Director of Service Operations and Supply Chain with Ulta Beauty, Inc. from April 2016 to June 2017; and Director of Stores with Field and Stream Outdoor Stores, a division of Dick’s Sporting Goods, Inc. from July 2015 to April 2016. Previously, he spent a total of 23 years at Target Corporation in a variety of operations, merchandising and property management positions.

Greg A. Jones has been our Vice President - Food & Health Sciences since April 2025. Prior to attaining this position, Mr. Jones served as our Vice President of Business since April 2024. Prior to joining Hawkins, Mr. Jones was a Global General Manager and Vice President for Kerry Taste & Nutrition, a global manufacturer of specialized food ingredients, from 2019-2024; and with Winpak, a global manufacturer of high barrier packaging and equipment, where he served as U.S. Director of Sales from 2017-2019 and U.S. Manager of sales from 2010-2017.

Douglas A. Lange has been our Vice President - Water Treatment since June 2020. Prior to attaining this position, Mr. Lange served the Company as General Manager and Product Development Manager for Water Treatment after joining the company in January 2019. Prior to joining the Company, Mr. Lange was with H.B. Fuller Company, a global supplier of special adhesives, where he served as Global Marketing Manager and Product Manager for specialty markets in electronics and wood products from 2011 to January 2019. Mr. Lange served in various roles in the specialty adhesives market for a total of 21 years prior to joining the Company.

Daniel A. Louismet has served as our Interim General Counsel since December 2025 and had previously served as our Associate General Counsel since September 2024. Prior to joining Hawkins, Mr. Louismet founded Minnesota Dealer Law through which he counseled franchised new vehicle dealerships from November 2023 to October 2024. Mr. Louismet served as General Counsel of the Minnesota Automobile Dealers Association from 2018 to October 2023 and as Associate General Counsel from 2015 to 2018. Previously, he was an attorney at Rice, Michels & Walther, LLP from 2013 to 2015. He is a member of the Minnesota Bar.

David J. Mangine has been our Vice President - Industrial Solutions since 2021. Prior to attaining this position, Mr. Mangine served as the Industrial Sales Manager from 2011 to 2021, after joining Hawkins in 2000 as an Account Manager.

Shirley A. Rozeboom has been our Vice President - Stauber since 2025. Prior to attaining this position, Ms. Rozeboom held the position of Vice President of Health and Nutrition from 2019 to 2025, Senior Vice President of Sales for Stauber from 2012 to 2019, Director of Sales from 2008 to 2012 and Account Executive from 2000 to 2008.

4